Health Canada approves ‘Season After the Morning After’ Pill
OTTAWA—Following positive, albeit controversial, results with its approval of non-prescription sales of the 72-hour ‘morning after’ pill (Levonorgestrel) and the 49-day ‘abortion pill’ (Mifegymiso), Health Canada has upped the ante.